Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Horwitz
    Horwitz
  9. Perales
    Perales
  10. Salles
    Salles

Groups

  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (26)
  4. Editorial (16)
  5. Review (11)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Martin Tallman (25)
  3. Andrew Zelenetz (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (15)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (351)
  2. Haematologica Meeting Reports (4)

Results (355)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years
    Journal Article

    Engelhardt, M.; Ihorst, G.; Landgren, O.; Pantic, M.; Reinhardt, H.; Waldschmidt, J.; May, A. M.; Schumacher, M.; Kleber, M.; Wäsch, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Precision medicine in diffuse large B-cell lymphoma: Hitting the target
    Journal Article

    Vermaat, J. S.; Pals, S. T.; Younes, A.; Dreyling, M.; Federico, M.; Aurer, I.; Radford, J.; Kersten, M. J.
    Haematologica (2015)

    Fulltext@MSK | Save
  • MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition
    Journal Article

    Kühn, M. W. M.; Hadler, M. J.; Daigle, S. R.; Koche, R. P.; Krivtsov, A. V.; Olhava, E. J.; Caligiuri, M. A.; Huang, G.; Bradner, J. E.; Pollock, R. M.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiology
    Journal Article

    Ishikawa, Y.; Maeda, M.; Pasham, M.; Aguet, F.; Tacheva-Grigorova, S. K.; Masuda, T.; Yi, H.; Lee, S. U.; Xu, J.; Teruya-Feldstein, J.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Multiple myeloma and infections: A population-based study on 9253 multiple myeloma patients
    Journal Article

    Blimark, C.; Holmberg, E.; Mellqvist, U. H.; Landgren, O.; Bjorkholm, M.; Hultcrantz, M.; Kjellander, C.; Turesson, I.; Kristinsson, S. Y.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Smoldering multiple myeloma: Special considerations surrounding treatment on versus off clinical trials
    Journal Article

    Manasanch, E. E.; Korde, N.; Mailankody, S.; Tageja, N.; Bhutani, M.; Roschewski, M.; Landgren, O.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Efficacy of idelalisib in Cll subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial
    Meeting Abstract

    Stilgenbauer, S.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • ABT-199 (Gdc-0199) in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: High response rates among patients with high risk disease features including unmutated IGHV
    Meeting Abstract

    Seymour, J. F.; Davids, M. S.; Pagel, J. M.; Kahl, B. S.; Wierda, W. G.; Puvvada, S.; Gerecitano, J. F.; Kipps, T. J.; Anderson, M. A.; Huang, D. C.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Quizartinib (Ac220) in patients with flt3-Itd(+) relapsed or refractory acute myeloid leukemia: Final results of a randomized phase 2 study
    Meeting Abstract

    Russell, N.; Tallman, M. S.; Goldberg, S.; Perl, A. E.; Marie, J. P.; Martinelli, G.; Larson, R. A.; Schiller, G.; Trone, D.; Gammon, G.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Molecular predictors of response to decitabine in chronic myelomonocytic leukemia
    Meeting Abstract

    Rossi, A.; Valencia, A.; Abdel-Wahab, O.; Masala, E.; Buchi, F.; Sanna, A.; Bosi, A.; Levis, A.; Allione, B.; Lunghi, M.; more...
    Haematologica (2014)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: